Skip to main content
Log in

To the Editor-in-Chief Advances in Contraception

  • Viewpoint
  • Published:
Advances in Contraception

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. HoppeG. (1987). Gestoden, an innovative progestogen.Adv. Contracept.,3, 159–166

    PubMed  Google Scholar 

  2. UngerR. (1987). Clinical investigations with a new gestodene-containing oral contraceptive. InGestodene M.Elstein, ed., Parthenon Publishing Group, England, pp. 81–89.

    Google Scholar 

  3. PetrieJ.C., O'BrienE.T., LittlerW.A. and DeSwietM. (1986). Recommendations on blood pressure measurements.Br. Med. J.,293, 611–615

    Google Scholar 

  4. ElgerW. (1987). In:Gestodene, M.Elstein, ed., Parthenon Publishing Group, England, p. 129

    Google Scholar 

  5. LosertW., Casals-StengalJ. and BuseM. (1985). Progestogens with antimineralcorticoid activity.Arzneim-Forsch./Drug Res.,35, 459–471

    Google Scholar 

  6. FotherbyK., TraynerI., LongthorneP.N., LeeB. and WatsonH.R. (1987). Metabolic investigations with Femodene.Contraception,35, 323–337

    PubMed  Google Scholar 

  7. CrosignaniP.G., VergadoroF., GiudiciG.A., VigottiG., VerganiC., FranceschettiF., CesanaB. and OrlandiR. (1978). A study of the metabolic effects of gestodene and desogestrel preparations. In:Gestodene, M.Elstein, ed., Parthenon Publishing Group, England, pp. 105–110

    Google Scholar 

  8. Schering (1987). Femovan. Der Erfolg unserer Forschung. Scientific brochure, p. 25

  9. FotherbyK. (1985). Oral contraceptives, lipids and cardiovascular disease.Contraception,31, 367–394

    PubMed  Google Scholar 

  10. FotherbyK. (1985). Effect of oral contraceptives on serum lipids and cardiovascular disease.Br. J. Fam. Plann.,11, 86–91

    Google Scholar 

  11. LaRosaJ.C. (1987). Reply to letter to the editor.Contraception,35, 305

    Google Scholar 

  12. FotherbyK. (1983). A metabolic assessment of different oral contraceptives.J. Obstet. Gynecol.,3 (suppl. 2), S77-S82

    Google Scholar 

  13. MammenE.E. (1982). Oral contraceptives and blood coagulation.Am. J. Obstet. Gynecol.,142, 781–790

    PubMed  Google Scholar 

  14. Van derViesJ. and DeVisser (1983). Endocrinological studies with desogestrel.Arzneim. Forsch./Drug Res.,33, 231–236

    Google Scholar 

  15. HoppeG. (1986). The pill, the heart and HDL.Adv. Contracept.,2, 405–411

    PubMed  Google Scholar 

References

  1. FotherbyK. (1985). Oral contraceptives, lipids and cardiovascular disease.Contraception,31, 367–394

    PubMed  Google Scholar 

  2. HoppeG. (1986). The pill, the heart and HDL: facts and fictions.Adv. Contracept.,2, 405–411

    PubMed  Google Scholar 

  3. HoppeG. (1987). Letter to the editor.Contraception,35, 3, 299–304

    PubMed  Google Scholar 

  4. MishkelM.A. (1987).Br. J. Fam. Plann.,12, 4, 31–34

    Google Scholar 

  5. EngelH.J., EngelE. and LichtlenP. (1985). Koronarsklerose und Herzinfarkt bei Jungen Frauen.Muench. Med. Wschr.,127, 415–417

    Google Scholar 

  6. WambachG. (1986). Wie beeinflussen Gestagene den Natriumhaushalt?Fortschr. Med.,104, 37–40

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fotherby, K., Hoppe, G. To the Editor-in-Chief Advances in Contraception. Adv Contracept 3, 349–353 (1987). https://doi.org/10.1007/BF01849293

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849293

Navigation